American Century Companies Inc. Raises Position in Doximity, Inc. $DOCS

Key Points

• American Century Companies Inc. increased its stake in Doximity, Inc. by 69.6% during the first quarter, owning about 0.10% of the company worth approximately $11 million.
• Several institutional investors have also made significant moves, with 87.19% of Doximity's stock now owned by institutions, indicating strong investor interest.
• Analyst ratings for Doximity are largely positive, with many raising their target prices and a mix of ratings, including two Strong Buy and ten Buy recommendations.

American Century Companies Inc. lifted its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 69.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 189,882 shares of the company's stock after purchasing an additional 77,955 shares during the quarter. American Century Companies Inc. owned about 0.10% of Doximity worth $11,019,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Ethic Inc. acquired a new stake in shares of Doximity in the 1st quarter worth $482,000. Element Capital Management LLC acquired a new stake in shares of Doximity in the 1st quarter worth $2,574,000. Liontrust Investment Partners LLP acquired a new stake in shares of Doximity in the 1st quarter worth $1,224,000. Fox Run Management L.L.C. acquired a new stake in shares of Doximity in the 1st quarter worth $1,461,000. Finally, Lord Abbett & CO. LLC boosted its position in shares of Doximity by 25.1% in the 1st quarter. Lord Abbett & CO. LLC now owns 819,177 shares of the company's stock worth $47,537,000 after purchasing an additional 164,614 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on DOCS shares. Mizuho lowered their price objective on Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a research report on Friday, May 16th. KeyCorp raised their price objective on Doximity from $65.00 to $70.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. Evercore ISI upgraded Doximity from an "in-line" rating to an "outperform" rating and raised their target price for the stock from $50.00 to $70.00 in a research note on Wednesday, July 9th. Needham & Company LLC raised their target price on Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Finally, BTIG Research upgraded Doximity from a "neutral" rating to a "buy" rating and set a $80.00 target price for the company in a research note on Monday, June 2nd. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $66.21.

Insider Buying and Selling at Doximity

In other Doximity news, Director Timothy S. Cabral sold 10,000 shares of Doximity stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director owned 6,360 shares in the company, valued at approximately $381,600. This trade represents a 61.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the transaction, the director owned 16,618 shares of the company's stock, valued at $948,721.62. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 36,000 shares of company stock worth $2,140,940. Insiders own 31.30% of the company's stock.

Doximity Price Performance

Shares of DOCS stock opened at $67.13 on Wednesday. The firm has a market capitalization of $12.57 billion, a price-to-earnings ratio of 67.13, a price-to-earnings-growth ratio of 4.10 and a beta of 1.36. The business has a fifty day moving average of $61.18 and a 200 day moving average of $60.45. Doximity, Inc. has a 1 year low of $35.32 and a 1 year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.Doximity's revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter last year, the company posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.